Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01671839 · ClinicalTrials.gov registry record · NA
Study of the Cabochon System for Improvement in the Appearance of Cellulite
A NA study of Gynoid Lipodystrophy, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 3
- Study locations
NCT01671839 is a NA study of Gynoid Lipodystrophy that has completed, run by Merz North America. The registered enrollment target is 55 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT01671839, a NA study of Gynoid Lipodystrophy, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Cabochon System for the improvement in the appearance of cellulite.
Conditions Studied
Interventions
- DEVICE Subcutaneous tissue release with the Cabochon System
Study Locations (3)
Louisiana
- The Coleman Center for Cosmetic and Dermatologic Surgery - Metairie
Maryland
- Maryland Laser Skin & Vein Institute - Hunt Valley
Massachusetts
- SkinCare Physicians - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01671839
The ClinicalTrials.gov registry entry for NCT01671839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gynoid Lipodystrophy appearing as the primary indexed condition, and to 1 intervention - of which Subcutaneous tissue release with the Cabochon System is the first listed.
NCT01671839 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Louisiana, Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01671839 about?
NCT01671839 is a clinical study titled "Study of the Cabochon System for Improvement in the Appearance of Cellulite". The purpose of this study is to evaluate the safety and effectiveness of the Cabochon System for the improvement in the appearance of cellulite.
What is the current status of trial NCT01671839?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2012-08. Estimated completion is 2015-12.
What conditions does trial NCT01671839 study?
This clinical trial studies the following conditions: Gynoid Lipodystrophy.
What interventions are being tested in trial NCT01671839?
The interventions under investigation include: Subcutaneous tissue release with the Cabochon System (DEVICE).
Who is sponsoring clinical trial NCT01671839?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01671839 being conducted?
This trial has 3 study locations across Louisiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.